Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Breast Cancer Endocrine aspects."'
Autor:
Aman U. Buzdar
Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of e
Autor:
Ingrid Espinoza, Lin Yang, Travis Vander Steen, Luciano Vellon, Elisabet Cuyàs, Sara Verdura, Lester Lau, Javier A. Menendez, Ruth Lupu
Publikováno v:
Aging-Us, 2022, vol. 14, núm. 3, p. 1200-1213
Articles publicats (IdIBGi)
Espinoza, Ingrid Yang, Lin Steen, Travis Vander Vellon, Luciano Cuyàs, Elisabet Verdura, Sara Lau, Lester Menéndez Menéndez, Javier Abel Lupu, Rut 2022 Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells Aging-Us 14 3 1200 1213
DUGiDocs – Universitat de Girona
instname
Articles publicats (IdIBGi)
Espinoza, Ingrid Yang, Lin Steen, Travis Vander Vellon, Luciano Cuyàs, Elisabet Verdura, Sara Lau, Lester Menéndez Menéndez, Javier Abel Lupu, Rut 2022 Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells Aging-Us 14 3 1200 1213
DUGiDocs – Universitat de Girona
instname
CCN1/CYR61 promotes angiogenesis, tumor growth and chemoresistance by binding to its integrin receptor αvβ3 in endothelial and breast cancer (BC) cells. CCN1 controls also tissue regeneration by engaging its integrin receptor α6β1 to induce fibro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28782d1fb84369276114570ee9c1468
https://doi.org/10.18632/aging.203882
https://doi.org/10.18632/aging.203882
